Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population

Neuropsychobiology

Volumn 50, Issue 4, 2004, Pages 301-304

  Inoue, Kazuyuki ^a   Itoh, Kunihiko ^a   Yoshida, Keizo ^b   Shimizu, Tetsuo ^b   Suzuki, Toshio ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Allele specific PCR; Genetic polymorphism; Major depressive disorder; Norepinephrine transporter

Indexed keywords

NORADRENALIN;

ADULT; ALLELE; ARTICLE; DEPRESSION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETICS; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; VOLUNTEER;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS;

EID: 8344260775     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080957     Document Type: Article

References (18)

1. Dencker SJ: The need for new and better antidepressants: Reboxetine a new option. Acta Psychiatr Scand Suppl 2000;402:6-11.
2. Kitayama S, Dohi T: Cellular and molecular aspects of monoamine neurotransmitter transporters. Jpn J Pharmacol 1996;72:195-208.
3. Glowinski J, Axelrod J: Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 1964;204:1318-1319.
4. Richelson E, Pfenning M: Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984;104:277-286.
5. Beique JC, Lavoie N, de Montigny C, Debonnel G: Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol 1998;349:129-132.
6. Porzgen P, Bonisch H, Bruss M: Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun 1995;215:1145-1150.
7. Pacholczyk T, Blakely RD, Amara SG: Expression cloning of a cocaine- and antidepressantsensitive human noradrenaline transporter. Nature 1991;350:350-354.
8. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P: Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 1996;67:523-532.
9. Owen D, Du L, Bakish D, Lapierre YD, Hrdina PD: Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res 1999;87:1-5.
10. Samochowiec J, Kucharska-Mazur J, Kaminski R, Smolka M, Rommelschpacher H, Wernicke C, Tymicz A, Schmidt LG: Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res 2002;111:229-233.
11. Sand PG, Mori T, Godau C, Stober G, Flachenecker P, Franke P, Nothen MM, Fritze J, Maier W, Lesch KP, Riederer P, Beckmann H, Deckert J: Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Lett 2002;333:41-44.
12. Leszczynska-Rodziewicz A, Czerski PM, Kapelski P, Godlewski S, Dmitrzak-Weglarz M, Rybakowski J, Hauser J: Polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: Lack of association. Neuropsychobiology 2002;45:182-185.
13. Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Muller-Siecheneder F, Zwanzger P, Schule C, Minov C, Behrens S, Rupprecht R, Hegerl U, Moller HJ, Bondy B: Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 2002;26:489-493.
14. Ryu SH, Lee SH, Lee HJ, Cha JH, Ham BJ, Han CS, Choi MJ, Lee MS: Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology 2004;49:174-177.
15. Montgomery SA, Åsberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
16. Buchner A, Faul F, Erdfelder E: G-Power: A priori, post hoc, and Compromise Power Analyses for the Macintosh (Version 2.1.1). Trier, University of Trier, 1996.
17. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA: Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 1997;17:8451-8458.
18. Haller J, Bakos N, Rodriguiz RM, Caron MG, Wetsel WC, Liposits Z: Behavioral responses to social stress in noradrenaline transporter knockout mice: Effects on social behavior and depression. Brain Res Bull 2002;58:279-284.